Renin-angiotensin-aldosterone system inhibitor dosing after initiation of outpatient sodium zirconium cyclosilicate therapy: The GALVANIZE RAASi real-world evidence study
media
posted on 2025-06-16, 10:06 authored by Adis journals on behalf of, Abiy Agiro, Alexandra Greatsinger, Fan Mu, Erin E. Cook, Jingyi Chen, Manasvi Sundar, Angela Zhao, Ellen Colman, Arun Malhotra<p><br></p><p dir="ltr"><b>Article full text</b></p><p dir="ltr">The above graphical abstract represents the opinions of the <b>authors</b>. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).</p>
